) --




) hit a new 52-week high Tuesday as it is currently trading at $34.35, above its previous 52-week high of $34.23 with 255,721 shares traded as of 10:39 a.m. ET. Average volume has been 2.1 million shares over the past 30 days.

Omnicare has a market cap of $3.86 billion and is part of the


sector and


industry. Shares are up 31.4% year to date as of the close of trading on Monday.

Omnicare, Inc. provides pharmaceuticals, and related pharmacy and ancillary services to long-term healthcare institutions.

  • Sign up for TheStreet's FREE Dividend and Income Investor Newsletter

TheStreet Ratings rates Omnicare as a


. The company's strengths can be seen in multiple areas, such as its increase in net income, revenue growth, largely solid financial position with reasonable debt levels by most measures, good cash flow from operations and solid stock price performance. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. You can view the full

Omnicare Ratings Report


See all

52-week high stocks

or get investment ideas from our

investment research center